Announcement on Preliminary Earnings Estimate for 2025
Filed with SSE · · 3 pages · Chinese
Youcare Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Youcare Pharmaceutical
- Indicative Announcement on Judicial Auction of Some Shares Held by Controlling Shareholders
- Announcement on Resignation of Director and Senior Management Member and Election of Employee Director
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Expected Loss in Performance for 2025
- Notice on Convening the 1st Extraordinary General Meeting in 2026
Later from Youcare Pharmaceutical
- Announcement on the Failure of Judicial Auction of Partial Shares Held by Controlling Shareholders
- Announcement on Changing and Closing Some Investment Projects Financed by Raised Funds and Using Residual Raised Funds to Add Investment Projects Financed by Raised Funds and Permanently Supplement Current Capital
- Announcement on Voluntary Disclosure of FDA Clinical Trial Approval for the Indication of YKYY018 Nebulized Inhalation for the Treatment and Prevention of Human Parainfluenza Virus Infection by Subsidiary
- Announcement on Voluntary Disclosure of Obtaining Clinical Trial Approval from the National Medical Products Administration for the Indications for the Treatment and Prevention of Human Bronchovirus Infection by the YKYY018 Inhalation Aerosol of Subsidiary
- Announcement on Resolutions of the 2025 Annual General Meeting
Follow Youcare Pharmaceutical into a list and get an email when it puts out news.
Follow Youcare Pharmaceutical